Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 11, 2013, Pages 1249-1256

  Kodama, Masaaki ^a   Murakami, Kazunari ^a   Okimoto, Tadayoshi ^a   Abe, Hisanori ^b   Sato, Ryugo ^a   Ogawa, Ryo ^a   Mizukami, Kazuhiro ^a   Shiota, Seiji ^a   Nakagawa, Yoshifumi ^a   Soma, Wataru ^b   Arita, Tsuyoshi ^b   Fujioka, Toshio ^a  

^a OITA UNIVERSITY   (Japan)

^b Department of Surgery   (Japan)

Author keywords

Atrophic gastritis; Gastric cancer; Helicobacter pylori; Intestinal metaplasia; OLGA system

Indexed keywords

ADULT; ARTICLE; ATROPHY; BACTERIAL CLEARANCE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STAGING; STOMACH ANTRUM; STOMACH CANCER; STOMACH MUCOSA;

AGED; ANTI-BACTERIAL AGENTS; ATROPHY; COHORT STUDIES; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; PROTON PUMP INHIBITORS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84885914341     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.838994     Document Type: Article

References (40)

1. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterol 1998;115:642-8.
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, YamakidoM, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-9.
3. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005;100:1037-42.
4. Kamada T, Hata J, Sugiu K, Kusunoki H, Ito M, Tanaka S, et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: Results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 2005;21:1121-6.
5. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, et al. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol 2007;42:S21-7.
6. Take S, Mizuno M, Ishiki K, Yoshida T, Ohara N, Yokota K, et al. The long-Term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol 2011;46:318-24.
7. Takata S, Ito M, Yoshihara M, Tanaka S, Imagawa S, Haruma K, et al. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: Preliminary report. J Gastroenterol Hepatol 2007;22:571-6.
8. Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, et al. Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharmacol Ther 2007;25:805-12.
9. Tashiro J, Miwa J, Tomita T, Matsubara Y, Oota Y. Gastric cancer detected after Helicobacter pylori eradication. Digestive Endoscopy 2007;19:167-73.
10. Ogura K, Hirata Y, Yanai A, Shibata W, Ohmae T, Mitsuno Y, et al. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer. J Clin Gastroenterol 2008;42:279-83.
11. Shiotani A, Uedo N, Iishi H, Yoshiyuki Y, Ishii M, Manabe N, et al. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion 2008;78:113-19.
12. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomised controlled trial. Lancet 2008;372:392-7.
13. Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 2009;125:2697-703.
14. Ito M, Takata S, Tatsugami M, Wada Y, Imagawa S, Matsumoto Y, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: A systematic review. J Gastroenterol 2009;44:365-71.
15. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-Analysis: Can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?. Ann Intern Med 2009;151:121-8.Erratum in Ann Intern Med 2009;151:121-8.
16. de Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: When is the horse out of the barn?. Am J Gastroenterol 2009;104:1342-5.
17. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
18. Rugge M, Genta RM; OLGA Group. Staging gastritis: An international proposal. Gastroenterol 2005;129:1807-8. Erratum in Gastroenterol 2006;131:1363.
19. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: A tutorial. Dig Liver Dis 2008;40:650-8.
20. Rugge M, de Boni M, Pennelli G, de Bona M, Giacomelli L, Fassan M, et al. Gastritis OLGA-staging and gastric cancer risk: A twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther 2010;31:1104-11.
21. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;3:87-97.
22. Satoh K, Kimura K, Taniguchi Y, Yoshida Y, Kihira K, Takimoto T, et al. Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am J Gastroenterol 1996;91: 963-9.
23. Liu Y, Uemura N, Xiao SD, Tytgat GN, Kate FJ. Agreement between endoscopic and histological gastric atrophy scores. J Gastroenterol 2005;40:123-7.
24. Kato S, Matsukura N, Togashi A, Masuda G, Matsuda N, Yamada N, et al. Sex differences in mucosal response to Helicobacter pylori infection in the stomach and variations in interleukin-8, COX-2 and trefoil factor family 1 gene expression. Aliment Pharmacol Ther 2004;20:S17-24.
25. Kodama M, Murakami K, Okimoto T, Abe T, Nakagawa Y, Mizukami K, et al. Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-Term observation. Digestion 2012;85:126-30.
26. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process-first american cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
27. Han JS, Jang JS, Choi SR, Kwon HC, Kim MC, Jeong JS, et al. A study of metachronous cancer after endoscopic resection of early gastric cancer. Scand J Gastroenterol 2011;46: 1099-104.
28. Kodama M, Murakami K, Okimoto T, Sato R, Uchida M, Abe T, et al. Ten-year prospective follow-up of histological changes at 5 points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol 2012;47:394-403.
29. Kim N, Park YS, Cho SI, Lee HS, Choe G, Kim IW, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter 2008;13:245-55.
30. Murakami K, Kodama M, Sato R, Okimoto T, Watanabe K, Fujioka T. Helicobacter pylori eradication and associated changes in the gastric mucosa. Expert Rev Anti Infect Ther 2005;3:757-64.
31. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-Term impact of Helicobacter pylori eradication on gastric histology: A systematic review and meta-Analysis. Helicobacter 2007;12:S32-8.
32. Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, et al. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: A meta-Analysis. Digestion 2011;83:253-60.
33. Murakami K, Fujioka T, Okimoto T, Mitsuishi Y, Oda T, Nishizono A, et al. Analysis of p53 gene mutations in Helicobacter pylori-Associated gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol 1999;34:474-7.
34. Kodama M, Murakami K, Okimoto T, Sato R, Watanabe K, Fujioka T. Expression of mutant type-p53 products in H. pylori-Associated chronic gastritis. World J Gastroenterol 2007;13:1541-6.
35. Shiotani A, Uedo N, Iishi H, Murao T, Kanzaki T, Kimura Y, et al. H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. J Gastroenterol 2012;47:988-98.
36. Ruiz B, Garay J, JohnsonW, Li D, RuggeM, Dixon MF, et al. Morphometric assessment of gastric antral atrophy: Comparison with visual evaluation. Histopathology 2001;39:235-42.
37. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al. Gastric mucosal atrophy: Interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249-59.
38. Kato S, Matsukura N, Tsukada K, Matsuda N, Mizoshita T, Tsukamoto T, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: Incidence and pathological characteristics. Cancer Sci 2007;98:790-4.
39. Azuma T, Yamazaki S, Yamakawa A, Ohtani M, Muramatsu A, Suto H, et al. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis 2004;189:820-7.
40. Abe T, Kodama M, Murakami K, Matsunari O, Mizukami K, Inoue K, et al. Impact of Helicobacter pylori CagA diversity on gastric mucosal damage: An immunohistochemical study of East-Asian-Type CagA. J Gastroenterol Hepatol 2011;26:688-93.